NCT06356441

Brief Summary

The aim of this randomized controlled study is to investigate whether the previously developed artificial intelligence model can triage post-radiotherapy magnetic resonance images of patients with nasopharyngeal carcinoma and assist radiologists in their interpretation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2024

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

April 4, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

2 years

First QC Date

April 4, 2024

Last Update Submit

April 9, 2024

Conditions

Keywords

artificial intelligenceimage reviewingmagnetic resonance imaging

Outcome Measures

Primary Outcomes (1)

  • sensitivity

    through study completion, an average of 2 years

Secondary Outcomes (8)

  • specificity

    through study completion, an average of 2 years

  • positive predictive value

    through study completion, an average of 2 years

  • negative predictive value

    through study completion, an average of 2 years

  • total time of interpretation for all the MR images

    through study completion, an average of 2 years

  • the rate of discussion with a third radiologist

    through study completion, an average of 2 years

  • +3 more secondary outcomes

Study Arms (2)

AI-supported reading

The AI model predicts the incidence of local recurrence. If the incidence is below 60%, one radiologist will interpret the MR images. If the incidence is above 60%, two radiologists will interpret the MR images. The radiologists will be provided with the predictive incidence and contours in their interpretation if desired. If two radiologists provide contradictory interpretations, a third radiologist will participate in the discussion to reach a consensus.

Diagnostic Test: AI

Standard double reading

The MR images will be interpreted by two radiologists, and in cases of disagreement, a third radiologist will be consulted to reach a consensus.

Interventions

AIDIAGNOSTIC_TEST

An artificial intelligence model predicts the risk and contours of local recurrence for MR images and triages them before radiologists interpret them.

AI-supported reading

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study enrolled patients with treatment naive nasopharyngeal carcinoma who have finished radiotherapy for 6 months or more and have no tumor residue in previous examinations.

You may qualify if:

  • Patients with treatment naive nasopharyngeal carcinoma who had finished radiotherapy for 6 months or more
  • The previous magnetic resonance imaging examination had showed complete remission in the primary site
  • Images are acquired using a 3T magnetic resonance imaging device, including unenhanced T1-weighted and T2-weighted sequences and contrast-enhanced T1-weighted sequences

You may not qualify if:

  • Patients are enrolled in this study for a specific magnetic resonance imaging scan and not for subsequent follow-up magnetic resonance imaging scans.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Yat-Sen University Cancer Center

Guangzhou, Guangdong, 510060, China

Location

Related Publications (1)

  • OuYang PY, He Y, Guo JG, Liu JN, Wang ZL, Li A, Li J, Yang SS, Zhang X, Fan W, Wu YS, Liu ZQ, Zhang BY, Zhao YN, Gao MY, Zhang WJ, Xie CM, Xie FY. Artificial intelligence aided precise detection of local recurrence on MRI for nasopharyngeal carcinoma: a multicenter cohort study. EClinicalMedicine. 2023 Aug 30;63:102202. doi: 10.1016/j.eclinm.2023.102202. eCollection 2023 Sep.

    PMID: 37680944BACKGROUND

Study Officials

  • Fang-Yun Xie

    Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

April 4, 2024

First Posted

April 10, 2024

Study Start

April 1, 2024

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

April 10, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations